1. Home
  2. SGHT vs SGC Comparison

SGHT vs SGC Comparison

Compare SGHT & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • SGC
  • Stock Information
  • Founded
  • SGHT 2011
  • SGC 1920
  • Country
  • SGHT United States
  • SGC United States
  • Employees
  • SGHT N/A
  • SGC N/A
  • Industry
  • SGHT Medical Specialities
  • SGC Apparel
  • Sector
  • SGHT Health Care
  • SGC Consumer Discretionary
  • Exchange
  • SGHT Nasdaq
  • SGC Nasdaq
  • Market Cap
  • SGHT 304.4M
  • SGC 281.4M
  • IPO Year
  • SGHT 2021
  • SGC N/A
  • Fundamental
  • Price
  • SGHT $3.54
  • SGC $16.42
  • Analyst Decision
  • SGHT Buy
  • SGC Strong Buy
  • Analyst Count
  • SGHT 7
  • SGC 2
  • Target Price
  • SGHT $6.27
  • SGC $22.50
  • AVG Volume (30 Days)
  • SGHT 234.0K
  • SGC 48.6K
  • Earning Date
  • SGHT 11-07-2024
  • SGC 11-06-2024
  • Dividend Yield
  • SGHT N/A
  • SGC 3.41%
  • EPS Growth
  • SGHT N/A
  • SGC 79.86
  • EPS
  • SGHT N/A
  • SGC 0.82
  • Revenue
  • SGHT $79,543,000.00
  • SGC $567,509,000.00
  • Revenue This Year
  • SGHT $2.18
  • SGC $5.31
  • Revenue Next Year
  • SGHT $8.14
  • SGC $3.85
  • P/E Ratio
  • SGHT N/A
  • SGC $20.05
  • Revenue Growth
  • SGHT N/A
  • SGC 4.19
  • 52 Week Low
  • SGHT $3.16
  • SGC $11.66
  • 52 Week High
  • SGHT $8.45
  • SGC $21.80
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 36.40
  • SGC 43.16
  • Support Level
  • SGHT $3.52
  • SGC $16.51
  • Resistance Level
  • SGHT $3.73
  • SGC $17.40
  • Average True Range (ATR)
  • SGHT 0.20
  • SGC 0.51
  • MACD
  • SGHT 0.01
  • SGC -0.12
  • Stochastic Oscillator
  • SGHT 24.54
  • SGC 0.00

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About SGC Superior Group of Companies Inc.

Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.

Share on Social Networks: